Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

What is the patent landscape for Doxercalciferol, and when can generic versions of Doxercalciferol launch?

Doxercalciferol is a drug marketed by Hikma Pharms Llc, Rising Pharms Inc, Sandoz Inc, Akorn Inc, and West-ward Pharms Int. and is included in six NDAs.

The generic ingredient in DOXERCALCIFEROL is doxercalciferol. There are nine drug master file entries for this compound. Nine suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the doxercalciferol profile page.

Summary for Tradename: DOXERCALCIFEROL

Suppliers / Packagers: see list5
Bulk Api Vendors: see list34
Clinical Trials: see list6
Patent Applications: see list237
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DOXERCALCIFEROL at DailyMed

Pharmacology for Tradename: DOXERCALCIFEROL

Drug ClassVitamin D2 Analog
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Pharms Llc
INJECTABLE;INJECTION091101-001Aug 30, 2013APRXNoNo► Subscribe► Subscribe
Akorn Inc
INJECTABLE;INJECTION203929-001May 7, 2015APRXNoNo► Subscribe► Subscribe
Rising Pharms Inc
CAPSULE;ORAL201518-003Sep 9, 2016ABRXNoNo► Subscribe► Subscribe
West-ward Pharms Int
CAPSULE;ORAL091433-001Sep 23, 2011ABRXNoNo► Subscribe► Subscribe
Rising Pharms Inc
CAPSULE;ORAL201518-001Sep 9, 2016ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus